Utility of Mesalazine in Familial Adenomatous Polyposis: Clinical Report of Reduction of Polyp Size in Patients with Ulcerative Colitis, and Safety Examination in Familial Adenomatous Polyposis Patients

This report provides basic information for planning a double-blind, randomized, clinical trial that aims to show mesalazine ’s potential to suppress intestinal polyp development in FAP.Pharmacology 2019;104:51 –56
Source: Pharmacology - Category: Drugs & Pharmacology Source Type: research